Trial Profile
Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB [integrated backscatter] echo and Black Blood MRI [magnetic resonance imaging]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms ACAP
- 06 May 2008 New trial record.